NCT05463510 is a clinical trial of Videodermoscopy in Nevus, Pigmented, sponsored by Istanbul Training and Research Hospital.

Who is sponsoring NCT05463510?

NCT05463510 is sponsored by Istanbul Training and Research Hospital.

What drugs are being tested in NCT05463510?

Interventions in NCT05463510: Videodermoscopy.

What condition does NCT05463510 study?

NCT05463510 studies Nevus, Pigmented.

Is NCT05463510 still recruiting?

NCT05463510 is currently completed. Last updated 19 July 2022.

Last reviewed 2022-07-19 · How we verify

NCT05463510

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dermoscopic Monitoring of Pediatric Melanocytic Nevi Regarding Pattern and Diameter Changes

Completed Last updated 19 July 2022

What this trial tests

trial testing Videodermoscopy in Nevus, Pigmented in 50 participants. Completed in 25 April 2022.

Timeline

25 March 2022

Primary endpoint
25 April 2022

25 April 2022

Quick facts

Lead sponsor	Istanbul Training and Research Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	50
Start date	25 March 2022
Primary completion	25 April 2022
Estimated completion	25 April 2022
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Videodermoscopy

Conditions studied

Nevus, Pigmented — all drugs for Nevus, Pigmented →

Sponsor

Istanbul Training and Research Hospital

Who can join

Adults 1 to 18, any sex, with Nevus, Pigmented. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Childhood and adolescence are a dynamic process in terms of nevogenesis, and the development and growth of new melanocytic nevus is frequently observed. Melanomas, although rare, can also be seen in the pediatric age group. Therefore, nevus monitoring with videodermoscopy may be necessary in the pediatric age group. Aim of our study is to show the dynamic pattern and diameter modifications in pediatric nevi.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Istanbul Training and Research Hospital trials

Trials by the same sponsor.

NCT07499713 — Association of Serum VEGF-A and VCAM-1 Levels With Nailfold Capilleroscopic Alterations in Alopecia Areata · enrolling by invitation
NCT07335822 — The Effectiveness of Low-Level Laser Therapy in the Treatment of Meralgia Paresthetica · NA · recruiting
NCT07363187 — Nailfold Capillaroscopy and Endothelial Biomarkers in Healthcare Workers Exposed to Chronic Low-Dose Ionizing Radiation · not yet recruiting
NCT07415291 — CNN-Based AI Versus Physicians for Solitary Skin Lesion Diagnosis · active not recruiting
NCT07150702 — Effects of Close Follow-up on Patients With Low Back Pain · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05463510 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Istanbul Training and Research Hospital
Last refreshed: 19 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05463510.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing